While studies across various cancers have highlighted the efficacy of ferroptosis induction, particularly by inhibiting GPX4 and AIFM2, in eliminating apoptosis-resistant cancer cells, the exploration of ferroptosis in the context of AML remains relatively limited. Here, GPX4 is linked to acute myeloid leukemia.